From surviving to thriving: cardio-oncology research,prevention and treatment ($2M)
From surviving to thriving: cardio-oncology research, prevention and treatment ($2M)
Better treatments have increased survival rates, yet many cancer therapies can lead to significant cardiac disease years later. Cedars has established a new cardio-oncology program to identify patients at higher risk for developing cardiovascular problems, to provide appropriate surveillance, and to initiate early treatment when needed.
“Interdisciplinary collaboration between oncology and cardiology, between the bench and the bedside, is helping us to offer the best care for our patients and is leading the way for cancer survivors in Canada.”
Dr. Negareh Mousavi
Director, Cardio-oncology Program, MUHC
More news
Giving Patients Back What Cancer Took Away
Plastic surgeon Dr. Josh Vorstenbosch, Director of the McGill University Health Centre (MUHC)’s Surgical Lymphedema Program, wants to “give patients back what cancer took away,” he says.
With over $50M raised, World Cancer Day sees us halfway to our goal. Help us reach $100M
On World Cancer Day 2024, the Cedars Cancer Foundation and the Montreal General Hospital Foundation launched our joint fundraising campaign, Together Against Cancer. Thanks to our generous donors, we’re halfway to our $100M fundraising goal.
Better Access to Clinical Trials Could Save the Lives of Cancer Patients
After coughing up blood one day, Armen, a security guard at the Montreal General Hospital (MGH-MUHC), was diagnosed with stage 3 lung cancer.